Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $1.28 billion. The enterprise value is $622.28 million.

Market Cap	1.28B
Enterprise Value	622.28M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

DYN has 141.51 million shares outstanding. The number of shares has increased by 53.90% in one year.

Current Share Class	141.51M
Shares Outstanding	141.51M
Shares Change (YoY)	+53.90%
Shares Change (QoQ)	+7.78%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	73.64%
Float	121.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.53
P/TBV Ratio	1.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.35, with a Debt / Equity ratio of 0.03.

Current Ratio	20.35
Quick Ratio	20.00
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.01% and return on invested capital (ROIC) is -41.47%.

Return on Equity (ROE)	-64.01%
Return on Assets (ROA)	-39.92%
Return on Invested Capital (ROIC)	-41.47%
Return on Capital Employed (ROCE)	-57.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.92M
Employee Count	191
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.25% in the last 52 weeks. The beta is 1.08, so DYN's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-78.25%
50-Day Moving Average	11.20
200-Day Moving Average	17.92
Relative Strength Index (RSI)	41.98
Average Volume (20 Days)	3,441,226

Short Selling Information

The latest short interest is 16.37 million, so 11.57% of the outstanding shares have been sold short.

Short Interest	16.37M
Short Previous Month	20.62M
Short % of Shares Out	11.57%
Short % of Float	13.43%
Short Ratio (days to cover)	10.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-397.10M
Pretax Income	-257.40M
Net Income	-367.13M
EBITDA	-395.31M
EBIT	-397.10M
Earnings Per Share (EPS)	-$3.62

Balance Sheet

The company has $677.49 million in cash and $23.33 million in debt, giving a net cash position of $654.16 million or $4.62 per share.

Cash & Cash Equivalents	677.49M
Total Debt	23.33M
Net Cash	654.16M
Net Cash Per Share	$4.62
Equity (Book Value)	668.97M
Book Value Per Share	5.89
Working Capital	655.62M

Cash Flow

In the last 12 months, operating cash flow was -$319.73 million and capital expenditures -$3.17 million, giving a free cash flow of -$322.89 million.

Operating Cash Flow	-319.73M
Capital Expenditures	-3.17M
Free Cash Flow	-322.89M
FCF Per Share	-$2.28

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.90%
Shareholder Yield	-53.90%
Earnings Yield	-28.76%
FCF Yield	-25.30%

Analyst Forecast

The average price target for DYN is $43.07, which is 377.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$43.07
Price Target Difference	377.49%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1